GeoVax Labs Statistics
Total Valuation
GeoVax Labs has a market cap or net worth of $11.48 million. The enterprise value is $5.97 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GeoVax Labs has 13.84 million shares outstanding. The number of shares has increased by 185.43% in one year.
| Current Share Class | 13.84M |
| Shares Outstanding | 13.84M |
| Shares Change (YoY) | +185.43% |
| Shares Change (QoQ) | +50.59% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 5.67% |
| Float | 13.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.09 |
| Forward PS | 1.11 |
| PB Ratio | 1.73 |
| P/TBV Ratio | 2.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.55
| Current Ratio | 2.55 |
| Quick Ratio | 1.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,176.34 |
Financial Efficiency
Return on equity (ROE) is -462.31% and return on invested capital (ROIC) is -290.70%.
| Return on Equity (ROE) | -462.31% |
| Return on Assets (ROA) | -180.23% |
| Return on Invested Capital (ROIC) | -290.70% |
| Return on Capital Employed (ROCE) | -498.05% |
| Revenue Per Employee | $232,622 |
| Profits Per Employee | -$1.47M |
| Employee Count | 17 |
| Asset Turnover | 0.45 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.92% in the last 52 weeks. The beta is 3.71, so GeoVax Labs's price volatility has been higher than the market average.
| Beta (5Y) | 3.71 |
| 52-Week Price Change | -44.92% |
| 50-Day Moving Average | 1.40 |
| 200-Day Moving Average | 2.40 |
| Relative Strength Index (RSI) | 32.36 |
| Average Volume (20 Days) | 507,424 |
Short Selling Information
The latest short interest is 815,234, so 5.89% of the outstanding shares have been sold short.
| Short Interest | 815,234 |
| Short Previous Month | 610,609 |
| Short % of Shares Out | 5.89% |
| Short % of Float | 5.92% |
| Short Ratio (days to cover) | 1.09 |
Income Statement
In the last 12 months, GeoVax Labs had revenue of $3.95 million and -$24.99 million in losses. Loss per share was -$4.82.
| Revenue | 3.95M |
| Gross Profit | -19.76M |
| Operating Income | -25.14M |
| Pretax Income | -26.92M |
| Net Income | -24.99M |
| EBITDA | -25.05M |
| EBIT | -25.14M |
| Loss Per Share | -$4.82 |
Full Income StatementBalance Sheet
The company has $5.51 million in cash and n/a in debt, giving a net cash position of $5.51 million or $0.40 per share.
| Cash & Cash Equivalents | 5.51M |
| Total Debt | n/a |
| Net Cash | 5.51M |
| Net Cash Per Share | $0.40 |
| Equity (Book Value) | 5.05M |
| Book Value Per Share | 0.48 |
| Working Capital | 4.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.68 million and capital expenditures -$20,653, giving a free cash flow of -$24.70 million.
| Operating Cash Flow | -24.68M |
| Capital Expenditures | -20,653 |
| Free Cash Flow | -24.70M |
| FCF Per Share | -$1.78 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -635.83% |
| Pretax Margin | -631.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GeoVax Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -185.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -217.71% |
| FCF Yield | -215.13% |
Analyst Forecast
The average price target for GeoVax Labs is $13.40, which is 1,489.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.40 |
| Price Target Difference | 1,489.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on January 31, 2024. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Jan 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
GeoVax Labs has an Altman Z-Score of -28.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.65 |
| Piotroski F-Score | 2 |